Cambridge, MA, United States of America

Cecilia Fernandez

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Editas Medicine, Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cecilia Fernandez. Retrieved from https://idiyas.com/inventor/cecilia-fernandez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cecilia Fernandez: Innovator in RNA Analysis

Introduction

Cecilia Fernandez is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the analysis of guide RNA molecules. Her work is crucial for advancements in genetic research and therapeutic applications.

Latest Patents

Cecilia holds 1 patent titled "Methods and systems for analyzing guide RNA molecules." This patent focuses on innovative methods for assessing a sample of guide RNAs (gRNAs), which are essential for various genetic engineering techniques.

Career Highlights

Cecilia is currently employed at Editas Medicine, Inc., a leading company in the field of gene editing. Her role involves developing cutting-edge technologies that enhance the understanding and application of RNA molecules in genetic research.

Collaborations

Cecilia has collaborated with notable colleagues, including Georgia Giannoukos and Luis A Barrera. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the field of biotechnology.

Conclusion

Cecilia Fernandez is a key figure in the biotechnology sector, with her patent and work at Editas Medicine, Inc. contributing to significant advancements in RNA analysis. Her innovative spirit and collaborative efforts continue to drive progress in genetic research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…